EB-1A Case Study: Approval for Scientist from Costa Rica

The EB-1A category requires evidence that an applicant has sustained national or international acclaim and stands among the small percentage at the very top of the field. A common assumption is that this kind of recognition comes only late in a career, and our client had completed his Ph.D. a few years earlier.  The challenge, then, was showing that the recognition he already earned through academic research was not limited to one project or one stage of his career.  

His work had evolved from university research into industry, where he was applying gene-editing methods to the development of treatments for rare genetic diseases. The legal team needed to document that his influence in the academic field had continued over time and followed him into an industry position.   

The legal team presented the client’s research in the context of the diseases it targets. According to the National Institutes of Health, more than 10,000 rare diseases have been identified and only about 5% have an approved treatment. This statistic emphasizes the broader importance of research aimed at identifying new treatments.   

The team mapped his record to 4 of the 10 EB-1A regulatory criteria, focusing on areas that documented both the significance of his research and the recognition he had earned over time. Because his career in genetics began well before his doctorate, the evidence drew on every stage of it, so the case did not rest on the number of years since his Ph.D.  

The client has authored more than a dozen peer-reviewed articles, which have been cited over 200 times and published in some of the most selective journals in biology and genetics, meeting the criterion for scholarly authorship.  Independent evaluations from leaders in genomics, including a Nobel Prize laureate in gene editing, explained how his work had influenced the field and established that he met the criterion for original contributions of major significance. 

His record also showed that other scientists and research institutions trusted his expertise.  His service as a journal editor and peer reviewer, as a proposal evaluator for his home country’s national research agency, and as a juror in a research competition supported the EB-1A criterion for judging the work of others. 

Recognition of his research also continued across different stages of his career. A leading professional society in human genetics honored his work twice, with each recognition coming from a pool of more than 1,000 candidates, satisfying the criterion for nationally or internationally recognized awards. Years later, his selection as 1 of only 2 research fellows from more than 200 applicants provided additional evidence that his standing in the field continued as he moved from academia into industry.  

Together, these 4 criteria formed the basis of the approved petition: scholarly authorship, original contributions of major significance, judging the work of others, and nationally or internationally recognized awards. 

USCIS approved the EB-1A petition with Premium Processing and without an RFE. With this approval, the client can take the next step toward U.S. permanent residency and continue his research in the United States.